Skip to Content

5-Years Data: High-Dose Thoracic Radiotherapy Increases OS Significantly for Patients with Limited Stage of Small-Cell Lung Cancer

Compared with low-dose thoracic radiotherapy, a high dose twice daily can increase overall survival (OS) from 22.6 months to 43.6 months. In this MEDtalk, Bjørn Henning Grønberg, NTNU, Trondheim, Norway, presents interesting data from the study.

Bjørn H Grønberg

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top